NANOVIRICIDES, INC. Increase (Decrease) in Interest Payable, Net
NANOVIRICIDES, INC. (NNVC) reported Increase (Decrease) in Interest Payable, Net of $0 for the 12-month period ending 2019-06-30, per its 10-K filed 2020-10-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2020-10-13
- NANOVIRICIDES, INC. increase (decrease) in interest payable, net for the quarter ending 2019-06-30 was $0.00.
- NANOVIRICIDES, INC. increase (decrease) in interest payable, net for the quarter ending 2019-03-31 was $0.00.
- NANOVIRICIDES, INC. increase (decrease) in interest payable, net for the quarter ending 2018-12-31 was $0.00.
- NANOVIRICIDES, INC. increase (decrease) in interest payable, net for the quarter ending 2018-09-30 was $0.00.
- NANOVIRICIDES, INC. increase (decrease) in interest payable, net for fiscal 2019 was $0.00.
- NANOVIRICIDES, INC. increase (decrease) in interest payable, net for fiscal 2018 was -$41.67K.
- NANOVIRICIDES, INC. increase (decrease) in interest payable, net for fiscal 2017 was -$166.67K.
- NANOVIRICIDES, INC. increase (decrease) in interest payable, net for fiscal 2016 was -$166.67K, a 133.33% decline from fiscal 2015.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|---|
| 2019-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-13 | $0.00 derived: sum of 2 quarters · filed 2020-10-13 | $0.00 derived: sum of 3 quarters · filed 2020-10-13 | $0.00 10-K · filed 2020-10-13 |
| 2019-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-15 | $0.00 derived: sum of 2 quarters · filed 2019-05-15 | $0.00 10-Q · filed 2019-05-15 | $0.00 derived: sum of 4 quarters · filed 2020-10-13 |
| 2018-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-14 | $0.00 10-Q · filed 2019-02-14 | $0.00 derived: sum of 3 quarters · filed 2020-10-13 | $0.00 derived: sum of 4 quarters · filed 2020-10-13 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-14 | $0.00 derived: sum of 2 quarters · filed 2020-10-13 | $0.00 derived: sum of 3 quarters · filed 2020-10-13 | $0.00 derived: sum of 4 quarters · filed 2020-10-13 |
| 2018-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-13 | $0.00 derived: sum of 2 quarters · filed 2020-10-13 | $0.00 derived: sum of 3 quarters · filed 2020-10-13 | -$41.67K 10-K · filed 2020-10-13 |
| 2018-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-15 | $0.00 derived: sum of 2 quarters · filed 2019-05-15 | -$41.67K 10-Q · filed 2019-05-15 | -$83.33K derived: sum of 4 quarters · filed 2019-08-23 |
| 2017-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-14 | -$41.67K 10-Q · filed 2019-02-14 | -$83.33K derived: sum of 3 quarters · filed 2019-08-23 | -$125.00K derived: sum of 4 quarters · filed 2019-08-23 |
| 2017-09-30 | -$41.67K 10-Q · filed 2018-11-14 | -$83.33K derived: sum of 2 quarters · filed 2019-08-23 | -$125.00K derived: sum of 3 quarters · filed 2019-08-23 | -$166.67K derived: sum of 4 quarters · filed 2019-08-23 |
| 2017-06-30 | -$41.67K derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-23 | -$83.33K derived: sum of 2 quarters · filed 2019-08-23 | -$125.00K derived: sum of 3 quarters · filed 2019-08-23 | -$166.67K 10-K · filed 2019-08-23 |
| 2017-03-31 | -$41.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-21 | -$83.33K derived: sum of 2 quarters · filed 2018-05-21 | -$125.00K 10-Q · filed 2018-05-21 | -$166.67K derived: sum of 4 quarters · filed 2018-10-12 |
| 2016-12-31 | -$41.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-20 | -$83.33K 10-Q · filed 2018-02-20 | -$125.00K derived: sum of 3 quarters · filed 2018-10-12 | -$166.67K derived: sum of 4 quarters · filed 2018-10-12 |
| 2016-09-30 | -$41.67K 10-Q · filed 2017-11-14 | -$83.33K derived: sum of 2 quarters · filed 2018-10-12 | -$125.00K derived: sum of 3 quarters · filed 2018-10-12 | -$166.67K derived: sum of 4 quarters · filed 2018-10-12 |
| 2016-06-30 | -$41.67K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-12 | -$83.33K derived: sum of 2 quarters · filed 2018-10-12 | -$125.00K derived: sum of 3 quarters · filed 2018-10-12 | -$166.67K 10-K · filed 2018-10-12 |
| 2016-03-31 | -$41.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | -$83.33K derived: sum of 2 quarters · filed 2017-05-15 | -$125.00K 10-Q · filed 2017-05-15 | $375.00K derived: sum of 4 quarters · filed 2017-09-28 |
| 2015-12-31 | -$41.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-14 | -$83.33K 10-Q · filed 2017-02-14 | $416.67K derived: sum of 3 quarters · filed 2017-09-28 | $416.67K derived: sum of 4 quarters · filed 2017-09-28 |
| 2015-09-30 | -$41.67K 10-Q · filed 2016-11-14 | $458.33K derived: sum of 2 quarters · filed 2017-09-28 | $458.33K derived: sum of 3 quarters · filed 2017-09-28 | |
| 2015-06-30 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | $500.00K derived: sum of 2 quarters · filed 2017-09-28 | $500.00K 10-K · filed 2017-09-28 | |
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10 | $0.00 10-Q · filed 2016-05-10 | ||
| 2014-12-31 | $0.00 10-Q · filed 2016-02-09 | |||
| 2014-06-30 | $0.00 10-K · filed 2016-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |